A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...
MedPage Today on MSN
GLP-1 Drugs Linked to Lower Epilepsy Risk in Diabetes Patients
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...
Taking GLP-1 medications like Ozempic is linked to a smaller risk of developing epilepsy than taking DPP-4 inhibitors. | Drug ...
A new analysis suggests GLP 1 receptor agonists, the diabetes drugs that include semaglutide, dulaglutide and liraglutide, ...
Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 ...
Cassava Sciences shares fell after the company said the Food and Drug Administration had put a hold on its epilepsy drug trial. The stock fell 15% to $2.41 in after-hours trading Thursday. Through the ...
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025, in ...
People with depression have a more than doubled risk of developing epilepsy, and the mental illness also makes epilepsy more ...
News-Medical.Net on MSN
Glucose-lowering drugs may reduce risk of developing epilepsy
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk ...
People with newly diagnosed epilepsy and a diagnosis of depression are more likely to fail their first antiseizure medication ...
Popular GLP-1 medications such as Ozempic may carry an unexpected link to a lower risk of epilepsy in people with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback